OBJECTIVE: Patients with chronic kidney disease (CKD) have the highest risk for atherosclerotic cardiovascular disease (CVD). Current interventions have been insufficiently effective in lessening excess incidence and mortality from CVD in CKD patients versus other high-risk groups. The mechanisms underlying the heightened risk remain obscure but may relate to differences in CKD-induced atherogenesis, including perturbation of macrophage cholesterol trafficking. METHODS AND RESULTS: We examined the impact of renal dysfunction on macrophage cholesterol homeostasis in the apoE(-/-) mouse model of atherosclerosis. Renal impairment induced by uninephrectomy dramatically increased macrophage cholesterol content, linked to striking impairment of macrophage cholesterol efflux. This blunted efflux was associated with downregulation of the cholesterol transporter ATP-binding cassette transporter A1 (ABCA1) and activation of the nuclear factor-kappa B (NF-kappaB). Treatment with the angiotensin receptor blocker (ARB) losartan decreased NF-kappaB and restored cholesterol efflux. CONCLUSIONS: Our findings show that mild renal dysfunction perturbs macrophage lipid homeostasis by inhibiting cholesterol efflux, mediated by decreased ABCA1 transporter and activation of NF-kappaB, and that ARB can restore cholesterol efflux.
OBJECTIVE:Patients with chronic kidney disease (CKD) have the highest risk for atherosclerotic cardiovascular disease (CVD). Current interventions have been insufficiently effective in lessening excess incidence and mortality from CVD in CKDpatients versus other high-risk groups. The mechanisms underlying the heightened risk remain obscure but may relate to differences in CKD-induced atherogenesis, including perturbation of macrophage cholesterol trafficking. METHODS AND RESULTS: We examined the impact of renal dysfunction on macrophage cholesterol homeostasis in the apoE(-/-) mouse model of atherosclerosis. Renal impairment induced by uninephrectomy dramatically increased macrophage cholesterol content, linked to striking impairment of macrophage cholesterol efflux. This blunted efflux was associated with downregulation of the cholesterol transporter ATP-binding cassette transporter A1 (ABCA1) and activation of the nuclear factor-kappa B (NF-kappaB). Treatment with the angiotensin receptor blocker (ARB) losartan decreased NF-kappaB and restored cholesterol efflux. CONCLUSIONS: Our findings show that mild renal dysfunction perturbs macrophage lipid homeostasis by inhibiting cholesterol efflux, mediated by decreased ABCA1 transporter and activation of NF-kappaB, and that ARB can restore cholesterol efflux.
Authors: M Yoshiyama; T Omura; K Takeuchi; S Kim; K Shimada; H Yamagishi; M Teragaki; K Akioka; H Iwao; J Yoshikawa Journal: J Mol Cell Cardiol Date: 2001-04 Impact factor: 5.000
Authors: Charles W Joyce; Marcelo J A Amar; Gilles Lambert; Boris L Vaisman; Beverly Paigen; Jamila Najib-Fruchart; Robert F Hoyt; Edward D Neufeld; Alan T Remaley; Donald S Fredrickson; H Bryan Brewer; Silvia Santamarina-Fojo Journal: Proc Natl Acad Sci U S A Date: 2001-12-18 Impact factor: 11.205
Authors: Carl P Sparrow; Joanne Baffic; My-Hanh Lam; Erik G Lund; Alan D Adams; Xuan Fu; Nancy Hayes; A Brian Jones; Karen L Macnaul; John Ondeyka; Sheo Singh; Jianhua Wang; Gaochao Zhou; David E Moller; Samuel D Wright; John G Menke Journal: J Biol Chem Date: 2002-01-14 Impact factor: 5.157
Authors: Irina Baranova; Tatyana Vishnyakova; Alexander Bocharov; Zhigang Chen; Alan T Remaley; John Stonik; Thomas L Eggerman; Amy P Patterson Journal: Infect Immun Date: 2002-06 Impact factor: 3.441
Authors: Patricia G Yancey; Anna E Bortnick; Ginny Kellner-Weibel; Margarita de la Llera-Moya; Michael C Phillips; George H Rothblat Journal: Arterioscler Thromb Vasc Biol Date: 2003-01-23 Impact factor: 8.311
Authors: Toshiaki Nakano; Shunsuke Katsuki; Mingxian Chen; Julius L Decano; Arda Halu; Lang Ho Lee; Diego V S Pestana; Angelo S T Kum; Rodrigo K Kuromoto; Whitney S Golden; Mario S Boff; Gabriel C Guimaraes; Hideyuki Higashi; Kevin J Kauffman; Takashi Maejima; Takehiro Suzuki; Hiroshi Iwata; Albert-László Barabási; Jon C Aster; Daniel G Anderson; Amitabh Sharma; Sasha A Singh; Elena Aikawa; Masanori Aikawa Journal: Circulation Date: 2019-01-02 Impact factor: 29.690
Authors: Shuwang Ge; Barbara Hertel; Ekaterina K Koltsova; Inga Sörensen-Zender; Jan T Kielstein; Klaus Ley; Hermann Haller; Sibylle von Vietinghoff Journal: Circ Res Date: 2013-08-01 Impact factor: 17.367
Authors: Manish P Ponda; Irina Barash; Jonathan E Feig; Edward A Fisher; Edward Y Skolnik Journal: Atherosclerosis Date: 2009-10-29 Impact factor: 5.162
Authors: Jason R Stubbs; John A House; A Jacob Ocque; Shiqin Zhang; Cassandra Johnson; Cassandra Kimber; Kyle Schmidt; Aditi Gupta; James B Wetmore; Thomas D Nolin; John A Spertus; Alan S Yu Journal: J Am Soc Nephrol Date: 2015-07-30 Impact factor: 10.121